CHRISTUS Cancer Treatment Center continuously monitors the quality of patient care provided for all cancer diagnoses. Through the American College of Surgeons Commission on Cancer web-based quality reporting tool-Cancer Program Practice Profile Reports (CP3R) – CHRISTUS Cancer Treatment Center monitors specific standard of care measures related to breast and colon cancer. These accountability measure have been endorsed by the National Quality Forum (NQF) and have been implemented for the purpose of fostering quality improvement at cancer programs awarded Commission on Cancer Accreditation.
The measure definitions are:
Radiation therapy is administered within 1 year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer.
Combination chemotherapy is considered or administered within 4 months (120 days) of diagnosis for women under 70 with AJCC T1cN0M0, or stage IB - III hormone receptor negative breast cancer.
Tamoxifen or third generation aromatase inhibitor is considered or administered within 1 year (365 days) of diagnosis for women with AJCC T1cN0M0, or stage IB - III hormone receptor positive breast cancer..
Radiation therapy is considered or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with ≥ 4 positive regional lymph nodes.
Adjuvant chemotherapy is considered or administered within 4 months (120 days) of diagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive) colon cancer.